Cargando…

Radiomic tumor phenotypes augment molecular profiling in predicting recurrence free survival after breast neoadjuvant chemotherapy

BACKGROUND: Early changes in breast intratumor heterogeneity during neoadjuvant chemotherapy may reflect the tumor’s ability to adapt and evade treatment. We investigated the combination of precision medicine predictors of genomic and MRI data towards improved prediction of recurrence free survival...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chitalia, Rhea, Miliotis, Marios, Jahani, Nariman, Tastsoglou, Spyros, McDonald, Elizabeth S., Belenky, Vivian, Cohen, Eric A., Newitt, David, van’t Veer, Laura J., Esserman, Laura, Hylton, Nola, DeMichele, Angela, Hatzigeorgiou, Artemis, Kontos, Despina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063641/ https://www.ncbi.nlm.nih.gov/pubmed/36997615 http://dx.doi.org/10.1038/s43856-023-00273-1

Ejemplares similares

Expert tumor annotations and radiomics for locally advanced breast cancer in DCE-MRI for ACRIN 6657/I-SPY1
por: Chitalia, Rhea, et al.
Publicado: (2022)

Impact of deformable registration methods for prediction of recurrence free survival response to neoadjuvant chemotherapy in breast cancer: Results from the ISPY 1/ACRIN 6657 trial
por: Thakran, Snekha, et al.
Publicado: (2022)

Prediction of Treatment Response to Neoadjuvant Chemotherapy for Breast Cancer via Early Changes in Tumor Heterogeneity Captured by DCE-MRI Registration
por: Jahani, Nariman, et al.
Publicado: (2019)

DIANA-miRPath v4.0: expanding target-based miRNA functional analysis in cell-type and tissue contexts
por: Tastsoglou, Spyros, et al.
Publicado: (2023)

Effect of Imaging Parameter Thresholds on MRI Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Subtypes
por: Lo, Wei-Ching, et al.
Publicado: (2016)

PlasmiR: A Manual Collection of Circulating microRNAs of Prognostic and Diagnostic Value
por: Tastsoglou, Spyros, et al.
Publicado: (2021)

Features of MRI stromal enhancement with neoadjuvant chemotherapy: a subgroup analysis of the ACRIN 6657/I-SPY TRIAL
por: Olshen, Adam, et al.
Publicado: (2017)

Manatee: detection and quantification of small non-coding RNAs from next-generation sequencing data
por: Handzlik, Joanna E., et al.
Publicado: (2020)

Current Landscape of Breast Cancer Imaging and Potential Quantitative Imaging Markers of Response in ER-Positive Breast Cancers Treated with Neoadjuvant Therapy
por: Jones, Ella F., et al.
Publicado: (2020)

Radiogenomics in brain, breast, and lung cancer: opportunities and challenges
por: Singh, Apurva, et al.
Publicado: (2021)

DIANA-miTED: a microRNA tissue expression database
por: Kavakiotis, Ioannis, et al.
Publicado: (2021)

Diffusion-Weighted MRI for Predicting Pathologic Complete Response in Neoadjuvant Immunotherapy
por: Li, Wen, et al.
Publicado: (2022)

microCLIP super learning framework uncovers functional transcriptome-wide miRNA interactions
por: Paraskevopoulou, Maria D., et al.
Publicado: (2018)

Effect of MR Imaging Contrast Thresholds on Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Subtypes: A Subgroup Analysis of the ACRIN 6657/I-SPY 1 TRIAL
por: Li, Wen, et al.
Publicado: (2016)

DIANA-microT 2023: including predicted targets of virally encoded miRNAs
por: Tastsoglou, Spyros, et al.
Publicado: (2023)

Comparison of Segmentation Methods in Assessing Background Parenchymal Enhancement as a Biomarker for Response to Neoadjuvant Therapy
por: Nguyen, Alex Anh-Tu, et al.
Publicado: (2020)

Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk
por: Magbanua, Mark Jesus M., et al.
Publicado: (2021)

A Poly(Lactic-co-Glycolic) Acid Nanovaccine Based on Chimeric Peptides from Different Leishmania infantum Proteins Induces Dendritic Cells Maturation and Promotes Peptide-Specific IFNγ-Producing CD8(+) T Cells Essential for the Protection against Experimental Visceral Leishmaniasis
por: Athanasiou, Evita, et al.
Publicado: (2017)

Impact of MRI Protocol Adherence on Prediction of Pathological Complete Response in the I-SPY 2 Neoadjuvant Breast Cancer Trial
por: Onishi, Natsuko, et al.
Publicado: (2020)

Tumor Sphericity Predicts Response in Neoadjuvant Chemotherapy for Invasive Breast Cancer
por: Li, Wen, et al.
Publicado: (2020)

Transcriptome Analysis Identifies Immune Markers Related to Visceral Leishmaniasis Establishment in the Experimental Model of BALB/c Mice
por: Agallou, Maria, et al.
Publicado: (2019)

Impact of Helicobacter pylori Infection and Its Major Virulence Factor CagA on DNA Damage Repair
por: Kontizas, Eleftherios, et al.
Publicado: (2020)

Association of miR-144 levels in the peripheral blood with COVID-19 severity and mortality
por: Madè, Alisia, et al.
Publicado: (2022)

Diffusion Tensor Imaging for Assessment of Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer
por: Wilmes, Lisa J., et al.
Publicado: (2016)

DIANA-mAP: Analyzing miRNA from Raw NGS Data to Quantification
por: Alexiou, Athanasios, et al.
Publicado: (2020)

Peryton: a manual collection of experimentally supported microbe-disease associations
por: Skoufos, Giorgos, et al.
Publicado: (2020)

DIANA-LncBase v3: indexing experimentally supported miRNA targets on non-coding transcripts
por: Karagkouni, Dimitra, et al.
Publicado: (2020)

MRI Enhancement in Stromal Tissue Surrounding Breast Tumors: Association with Recurrence Free Survival following Neoadjuvant Chemotherapy
por: Jones, Ella F., et al.
Publicado: (2013)

Breast DCE-MRI Kinetic Heterogeneity Tumor Markers: Preliminary Associations With Neoadjuvant Chemotherapy Response()
por: Ashraf, Ahmed, et al.
Publicado: (2015)

Computational drug repositioning for the identification of new agents to sensitize drug-resistant breast tumors across treatments and receptor subtypes
por: Yu, Katharine, et al.
Publicado: (2023)

Accuracy of breast MRI in evaluating nodal status after neoadjuvant therapy in invasive lobular carcinoma
por: Abel, Mary Kathryn, et al.
Publicado: (2021)

Resampling and harmonization for mitigation of heterogeneity in image parameters of baseline scans
por: Singh, Apurva, et al.
Publicado: (2022)

Pretreatment vitamin D level and response to neoadjuvant chemotherapy in women with breast cancer on the I-SPY trial (CALGB 150007/150015/ACRIN6657)
por: Clark, Amy S, et al.
Publicado: (2014)

Exploration of PET and MRI radiomic features for decoding breast cancer phenotypes and prognosis
por: Huang, Shih-ying, et al.
Publicado: (2018)

Clinically Meaningful Tumor Reduction Rates Vary by Prechemotherapy MRI Phenotype and Tumor Subtype in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)
por: Mukhtar, Rita A., et al.
Publicado: (2013)

Are radiomic signatures ready for incorporation in the clinical pipeline?
por: Singh, Apurva, et al.
Publicado: (2023)

DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions
por: Karagkouni, Dimitra, et al.
Publicado: (2018)

Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)
por: Esserman, Laura J., et al.
Publicado: (2011)

DNA repair deficiency biomarkers and the 70-gene ultra-high risk signature as predictors of veliparib/carboplatin response in the I-SPY 2 breast cancer trial
por: Wolf, Denise M., et al.
Publicado: (2017)

Effect of Inter-Reader Variability on Diffusion-Weighted MRI Apparent Diffusion Coefficient Measurements and Prediction of Pathologic Complete Response for Breast Cancer
por: Le, Nu N., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1doal3kdr7pm01s7np8gkonmlo